February 11, 2021Frontiers in PediatricsOpen Access

Management of Patent Ductus Arteriosus in Premature Infants in 2020

View Full Paper

Ask AI

Bookmark

Why the study?

The decision to treat PDA in premature infants remains debated due to a shortage of demonstrated long-term benefits, leading to practice variations across sub-specialties and centers.

Population

Premature infants with PDA

Design

Review

Authors

SPSarah ParkersonUniversity of Tennessee Health Science Center RPRanjit PhilipUniversity of Tennessee Health Science Center ATAjay J. TalatiUniversity of Tennessee Health Science Center

Discussion

Member takes

Implication

Transcatheter PDA closure may warrant consideration in select premature infants; leaves open the need for randomized trials to guide adoption.

Structured PICO

Population

Premature infants with patent ductus arteriosus (PDA)

Intervention

Patent ductus arteriosus (PDA) closure, including transcatheter PDA closure (TCPC)

This review summarizes the management of patent ductus arteriosus in premature infants, highlighting the emerging role of transcatheter PDA closure.

Cite This Study

Parkerson et al. (2021) studied this question.

synapsesocial.com/papers/6a8a418c4de818ad79d450fa https://doi.org/10.3389/fped.2020.590578

View Full Paper

Ask AI

Bookmark

Implication

Transcatheter PDA closure may warrant consideration in select premature infants; leaves open the need for randomized trials to guide adoption.